ERLN

gene
On this page

Also known as ELN

Summary

ERLN (endoregulin, HGNC:40032) is a protein-coding gene on chromosome 17q25.1, encoding Endoregulin (P0DI80). Inhibits the activity of the calcium ATPases ATP2A2/SERCA2 and ATP2A3/SERCA3 by decreasing their apparent affinity for Ca(2+).

Predicted to act upstream of or within negative regulation of ATPase-coupled calcium transmembrane transporter activity. Predicted to be located in endoplasmic reticulum membrane.

Source: NCBI Gene 100130933 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 6 total
  • MANE Select transcript: NM_001162997

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:40032
Approved symbolERLN
Nameendoregulin
Location17q25.1
Locus typegene with protein product
StatusApproved
AliasesELN
Ensembl geneENSG00000259120
Ensembl biotypeprotein_coding
OMIM620531
Entrez100130933

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 3 protein_coding

ENST00000556126, ENST00000579469, ENST00000911162

RefSeq mRNA: 1 — MANE Select: NM_001162997 NM_001162997

CCDS: CCDS54166

Canonical transcript exons

ENST00000579469 — 2 exons

ExonStartEnd
ENSE000026908367564737175647974
ENSE000027188807564625175646786

Expression profiles

Bgee: expression breadth ubiquitous, 155 present calls, max score 96.42.

FANTOM5 (CAGE): breadth broad, TPM avg 0.6127 / max 85.2959, expressed in 208 samples.

FANTOM5 promoters (5 alternative TSS)

Promoter IDTPM avgSamples expressed
1627620.235597
1627600.173394
1627640.102821
1627610.068028
1627630.033013

Top tissues by expression

234 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
spermCL:000001996.42gold quality
kidney epitheliumUBERON:000481991.71silver quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047390.65gold quality
left testisUBERON:000453385.46gold quality
right testisUBERON:000453484.50gold quality
ileal mucosaUBERON:000033182.93gold quality
testisUBERON:000047382.55gold quality
pancreatic ductal cellCL:000207982.35silver quality
mucosa of transverse colonUBERON:000499182.27gold quality
islet of LangerhansUBERON:000000682.25gold quality
right uterine tubeUBERON:000130282.09gold quality
adult mammalian kidneyUBERON:000008281.78gold quality
gall bladderUBERON:000211080.52gold quality
C1 segment of cervical spinal cordUBERON:000646979.69gold quality
duodenumUBERON:000211479.11gold quality
jejunal mucosaUBERON:000039978.44gold quality
spinal cordUBERON:000224077.83gold quality
bronchial epithelial cellCL:000232877.58gold quality
kidneyUBERON:000211377.41gold quality
body of stomachUBERON:000116176.69gold quality
bronchusUBERON:000218576.32gold quality
pancreasUBERON:000126476.17gold quality
rectumUBERON:000105275.72gold quality
epithelial cell of pancreasCL:000008375.64gold quality
metanephros cortexUBERON:001053375.31gold quality
cortex of kidneyUBERON:000122575.13gold quality
stomachUBERON:000094575.11gold quality
colonic mucosaUBERON:000031775.05gold quality
right lobe of liverUBERON:000111474.28gold quality
body of pancreasUBERON:000115073.99gold quality

Single-cell (SCXA)

Detected in 5 experiment(s), a significant marker in 4.

ExperimentMarker?Max mean expression
E-MTAB-10283yes1387.01
E-MTAB-10287yes25.31
E-GEOD-125970yes7.12
E-ANND-3yes4.50
E-HCAD-31no3.99

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

15 targeting ERLN, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-144-3P99.9473.982698
HSA-MIR-652-5P99.9167.49505
HSA-MIR-579-3P99.8671.663628
HSA-MIR-664B-3P99.8471.653590
HSA-MIR-6739-5P99.8067.872806
HSA-MIR-6733-5P99.7467.942759
HSA-MIR-6848-3P99.6466.49885
HSA-MIR-315399.5567.592337
HSA-MIR-6843-3P99.2666.42915
HSA-MIR-3925-5P99.2167.901466
HSA-MIR-589-5P98.7266.96927
HSA-MIR-6830-3P98.6268.071760
HSA-MIR-561-5P98.2568.131365
HSA-MIR-1178-5P95.8364.12504
HSA-MIR-286195.2465.471056

Cross-species orthologs

0 orthologs

Protein

Protein identifiers

EndoregulinP0DI80 (reviewed: P0DI80)

Alternative names: Small integral membrane protein 6

All UniProt accessions (1): P0DI80

UniProt curated annotations — full annotation on UniProt →

Function. Inhibits the activity of the calcium ATPases ATP2A2/SERCA2 and ATP2A3/SERCA3 by decreasing their apparent affinity for Ca(2+).

Subunit / interactions. Homooligomer. Can also form heterooligomers with other sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA) regulators ARLN, PLN, SLN and STRIT1/DWORF. Monomer. Interacts as a monomer with ATP2A2/SERCA2; the interaction results in inhibition of ATP2A2 Ca(2+) affinity.

Subcellular location. Endoplasmic reticulum membrane.

RefSeq proteins (1): NP_001156469* (*=MANE)

Domains & families (InterPro)

UniProt features (2 total): chain 1, transmembrane region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P0DI80-F177.260.28

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 830 (showing top): GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_UP, GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_UP, GOBP_REGULATION_OF_PROTEIN_POLYMERIZATION, GOBP_ACTIN_FILAMENT_BUNDLE_ORGANIZATION, GOBP_RESPIRATORY_GASEOUS_EXCHANGE_BY_RESPIRATORY_SYSTEM, GOBP_MUSCLE_TISSUE_DEVELOPMENT, CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN, GOBP_CIRCULATORY_SYSTEM_PROCESS, YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP, MODULE_45, GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP, GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP, GOBP_EXTRACELLULAR_MATRIX_ASSEMBLY, GOBP_MUSCLE_CELL_PROLIFERATION, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (3): endoplasmic reticulum membrane (GO:0005789), endoplasmic reticulum (GO:0005783), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
organelle membrane1
nuclear outer membrane-endoplasmic reticulum membrane network1
endoplasmic reticulum subcompartment1
cytoplasm1
endomembrane system1
intracellular membrane-bounded organelle1
cellular anatomical structure1

Protein interactions and networks

STRING

310 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ERLNARLNQ8WVX3805
ERLNSTRIT1P0DN84729
ERLNMRLNP0DMT0714
ERLNSLNO00631606
ERLNTBC1D3KA0A087X1G2571
ERLNCDRT15L2A8MXV6520
ERLNTBC1D3HP0C7X1479
ERLNTBC1D28Q2M2D7447
ERLNTBC1D3DA0A087WVF3444
ERLNSLC35G6P0C7Q6430
ERLNSLC35G3Q8N808419
ERLNCCDC144AA2RUR9419
ERLNSMIM5Q71RC9418
ERLNSPDYE4A6NLX3404
ERLNOR3A2P47893402

IntAct

0 interactions, top by confidence:

ESM2 similar proteins: A0A1B0GQX2, A0A1B0GTB2, A2BUT0, A2C0D2, A6BM34, A7M911, A8W3J7, B0JYB0, B1WS50, B2J4U1, B2Y1W9, B7JV08, B7KFH4, O19926, O29047, O70901, P0C0X9, P0C179, P0DI80, P27387, P29662, P30395, P31591, P58246, Q06GN1, Q06RE7, Q06SD5, Q06SI9, Q110N3, Q1ACL7, Q28053, Q28280, Q28748, Q28757, Q29149, Q32FX5, Q3J1A4, Q3M5W2, Q46H80, Q54YR4

Diamond homologs: P0DI80, Q3U0I6

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

6 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance4
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

186 predictions. Top by Δscore:

VariantEffectΔscore
17:75647365:TTCCA:Tacceptor_loss0.9900
17:75647366:TCCA:Tacceptor_loss0.9900
17:75647367:CCA:Cacceptor_loss0.9900
17:75647368:CA:Cacceptor_loss0.9900
17:75647369:AGA:Aacceptor_loss0.9900
17:75646367:CACAG:Cdonor_loss0.9800
17:75646368:ACAG:Adonor_loss0.9800
17:75646369:CAGG:Cdonor_loss0.9800
17:75646370:AGGTG:Adonor_loss0.9800
17:75646371:GGT:Gdonor_loss0.9800
17:75646372:GTGAG:Gdonor_loss0.9800
17:75646373:T:Adonor_loss0.9800
17:75646653:A:AGacceptor_gain0.9700
17:75646654:G:GGacceptor_gain0.9700
17:75647369:A:AGacceptor_gain0.9700
17:75647370:G:GGacceptor_gain0.9700
17:75646654:GTT:Gacceptor_gain0.9500
17:75647370:GATT:Gacceptor_gain0.9500
17:75646782:ATCAG:Adonor_loss0.9300
17:75646783:TCAGG:Tdonor_loss0.9300
17:75646784:CAG:Cdonor_loss0.9300
17:75646785:AGGT:Adonor_loss0.9300
17:75646786:GGTAA:Gdonor_loss0.9300
17:75646787:G:Tdonor_loss0.9300
17:75646788:T:Adonor_loss0.9300
17:75647553:TG:Tdonor_gain0.9200
17:75647370:GA:Gacceptor_gain0.9100
17:75646653:AGTT:Aacceptor_gain0.8900
17:75646654:GTTG:Gacceptor_gain0.8900
17:75646374:G:GTdonor_loss0.8600

AlphaMissense

403 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:75647509:T:CF45L0.927
17:75647511:T:AF45L0.927
17:75647511:T:GF45L0.927
17:75647424:G:CW16C0.869
17:75647424:G:TW16C0.869
17:75647456:T:AV27E0.843
17:75647443:G:AG23R0.842
17:75647443:G:CG23R0.842
17:75647436:G:CW20C0.840
17:75647436:G:TW20C0.840
17:75647501:C:AA42D0.823
17:75647434:T:AW20R0.820
17:75647434:T:CW20R0.820
17:75647419:T:CF15L0.817
17:75647421:C:AF15L0.817
17:75647421:C:GF15L0.817
17:75647450:T:CL25P0.806
17:75647447:G:AG24D0.802
17:75647446:G:CG24R0.774
17:75647497:T:CF41L0.774
17:75647499:T:AF41L0.774
17:75647499:T:GF41L0.774
17:75647422:T:AW16R0.772
17:75647422:T:CW16R0.772
17:75647483:T:GL36R0.770
17:75647489:T:GL38R0.769
17:75647444:G:AG23E0.760
17:75647512:G:CG46R0.753
17:75647467:T:CF31L0.746
17:75647469:C:AF31L0.746

dbSNP variants (sampled 300 via entrez): RS1000140249 (17:75646101 C>A), RS1000740986 (17:75644486 G>C), RS1001122212 (17:75645700 G>A), RS1001236558 (17:75645758 A>G), RS1005564698 (17:75646384 G>A,C), RS1005588108 (17:75647106 C>A,G), RS1005900357 (17:75647894 A>T), RS1006012548 (17:75646838 T>A,C), RS1007046490 (17:75646729 C>T), RS1007057708 (17:75646467 C>G,T), RS1007093534 (17:75645730 G>A), RS1007422382 (17:75647244 G>A), RS1008092852 (17:75644381 A>C,G), RS1008540575 (17:75644601 A>G), RS1009965943 (17:75645692 G>A)

Disease associations

OMIM: gene MIM:620531 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

13 total (human), top 13 by PubMed support.

ChemicalActions (top 5)PubMed papers
methyleugenolincreases expression1
sodium arseniteincreases expression1
abrineincreases expression1
Air Pollutantsincreases expression, increases abundance1
Benzo(a)pyreneaffects methylation1
Ethinyl Estradiolaffects expression1
Smokeincreases abundance, increases expression1
Tobacco Smoke Pollutiondecreases expression1
Triclosanincreases expression1
Valproic Aciddecreases expression1
Cyclosporineincreases expression1
Aflatoxin B1increases methylation1
Genisteinaffects expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.